<DOC>
	<DOC>NCT00767247</DOC>
	<brief_summary>Analysis of antihypertensive treatment efficacy.</brief_summary>
	<brief_title>Analysis of Antihypertensive Treatment Efficacy</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Antihypertensive Agents</mesh_term>
	<criteria>arterial hypertension intake of Atacand before study enrollment hypersensitivity to candesartan or any other ingredient of Atacand liver function impairment and/or cholestasis severe renal insufficiency (serum creatinine &gt; 265 Âµmol/L) Pregnant and lactating women</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>Arterial Hypertension</keyword>
</DOC>